Status:
NOT_YET_RECRUITING
Cerebellar Transcranial Direct Current Stimulation for Dysphagia After Supratentorial Stroke
Lead Sponsor:
Zhejiang Provincial People's Hospital
Conditions:
Dysphagia After Stroke
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
It is estimated that 400,000 to 800,000 people worldwide develop neurogenic dysphagia annually. Stroke represents the most common etiology, with approximately 65% of acute stroke patients experiencing...
Detailed Description
This multicentre randomized controlled trial will enroll 76 patients with dysphagia after stroke from Zhejiang Provincial People' s Hospital. All patients will be centrally randomized to either tDCS c...
Eligibility Criteria
Inclusion
- Patients with supratentorial stroke, confirmed by cranial MRI or CT as having cerebral infarction or hemorrhage;
- Stable vital signs after conventional treatment, with disease duration between 1 and 6 months;
- 30 ≤ age ≤75 years, male or female;
- Presence of dysphagia, drinking-induced coughing, and a Kubota Water Drinking Test grade of 3-5;
- Signed informed consent form.
Exclusion
- MRI-confirmed lesion involving the cerebellum;
- Unstable vital signs;
- Significant cognitive impairment (MMSE score ≤ 24);
- Presence of swallowing apraxia;
- Unwilling or unable to cooperate with treatment, or taking any medication that may affect swallowing function or nervous system activity.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT07212634
Start Date
December 1 2025
End Date
December 31 2027
Last Update
October 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.